摘要:
Described is biphasic composition for topical use, in particular for the treatment of acne and related skin blemishes, containing trichloroacetic acid and perfluorodecalin.
摘要:
The present invention relates to amorphous substances, crystals, pharmaceutical compositions, preparation methods and uses of a thiohydantoin compound or pharmaceutically acceptable salt thereof. Specifically, provided are an amorphous substance of a compound of formula I, 1,5-naphthalene disulfonate thereof, an amorphous substance and two crystals (having crystal form A and crystal form B, respectively) of the 1,5-naphthalene disulfonate thereof, and corresponding pharmaceutical compositions, as well as preparation methods for the products above and corresponding pharmaceutical uses.
摘要:
The present invention relates to cosmetical and pharmaceutical compositions containing Bacillus strains or fermentation broths thereof and to methods of producing and using such strains.
摘要:
Sodium hypochlorite-based compositions that are non-toxic and have antimicrobial and cleansing properties may include from about 0.025% to about 10% by weight of sodium hypochlorite. For example, the compositions may include less than 1% by weight of sodium hypochlorite (e.g., less than 0.5% by weight of sodium hypochlorite). The compositions may further include sodium laureth sulfate, cocamidopropyl betaine, cocamide MEA, disodium EDTA, and deionized water. Such compositions may be applied externally to a mammalian body through rinse-off or leave-on applications. Compositions also may be incorporated as a component of other products, such as deodorants, towelettes, or powders.
摘要:
Disclosed herein are synthetic peptides and compositions comprising the same, for the treatment and/or prophylaxis of a disease or a condition related to angiogenesis. Also disclosed herein are methods of treating and/or preventing a disease or a condition related to angiogenesis, by administering to a subject in need of such treatment a composition containing a therapeutically effective amount of a synthetic peptide of the present disclosure.